0
Letters to the Editor |

In reply

Maria-Joao Ribeiro, MD, PhD; Marie Vidailhet, MD; Philippe Remy, MD, PhD
[+] Author Affiliations

Copyright 2002 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

More Author Information
Arch Neurol. 2002;59(12):1973-1974. doi:
Text Size: A A A
Published online

We thank Fernandez and Friedman for their comments. Although the results they mention were obtained in a small number of subjects, they point out an unresolved question: whether patients with PD can have normal findings on 18F-dopa PET scans. From our results, one could extrapolate that the compensatory increase of the dopa decarboxylase might produce normal 18F-dopa PET scan findings despite the disappearance of 20% or 30% of the dopaminergic neurons. However, the study showing that 18F-dopa uptake is highly correlated to motor function suggests that when this uptake is normal, the motor performance is nearly normal. Finally, abnormal results on 18F-dopa PET scans have occurred in asymptomatic co-twins of patients with PD.1 Although this type of PD is probably genetic and may be different from the idiopathic form, this finding argues against the likelihood of PD symptoms without abnormal 18F-dopa PET scan findings. Finally, technical parameters for image acquisition and analysis might influence the ability to discriminate between normal and abnormal results on these scans. Consequently, reporting and following cases of PD that demonstrate normal findings on 18F-dopa PET scans and abnormal results on examinations using DAT ligands is of major interest.

Some of us were investigators for the REAL-PET Study,2 which measured the progression of Parkinson disease for 2 years using 18F-dopa in patients blindly assigned to treatment with ropinirole hydrochloride or levodopa. We cannot comment on this study because the data are still unpublished. However, the subjects with normal 18F-dopa PET scan findings at baseline who were excluded from the analysis also had normal PET scan results after 2 years of follow-up, which is very unlikely in patients with PD. Moreover, the caudate-putamen ratio in these subjects was abnormally high considering the usual pattern of dopaminergic denervation in PD.3 4 Unfortunately, it is possible that the PET scan analysis revealed misdiagnosis in these subjects. However, we recommend that our colleagues refer directly to the published data when available.

REFERENCES

Piccini  P, Burn  DJ, Ceravolo  R.  et al.  The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol. 1999;;45:577-- 582.
Whone  AL, Remy  P, Davis  M. The REAL-PET Study: slower progression in early Parkinson's disease treated with ropinirole compared with L-dopa [abstract]. Neurology. 2002;;58(suppl 3):A82-- A83.
Kish  SJ, Shannak  K, Hornykiewicz  O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. N Engl J Med. 1988;;318:876-- 880.
Brooks  DJ. The early diagnosis of Parkinson's disease. Ann Neurol. 1998;;44(suppl 1):S10-- S18.

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Piccini  P, Burn  DJ, Ceravolo  R.  et al.  The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol. 1999;;45:577-- 582.
Whone  AL, Remy  P, Davis  M. The REAL-PET Study: slower progression in early Parkinson's disease treated with ropinirole compared with L-dopa [abstract]. Neurology. 2002;;58(suppl 3):A82-- A83.
Kish  SJ, Shannak  K, Hornykiewicz  O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. N Engl J Med. 1988;;318:876-- 880.
Brooks  DJ. The early diagnosis of Parkinson's disease. Ann Neurol. 1998;;44(suppl 1):S10-- S18.

Correspondence

CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.